A citation-based method for searching scientific literature

Wei-Lei Yang, Zhen Lu, Jing Guo, Bryan M Fellman, Jing Ning, Karen H Lu, Usha Menon, Makoto Kobayashi, Samir M Hanash, Joseph Celestino, Steven J Skates, Robert C Bast. Cancer 2020
Times Cited: 8







List of co-cited articles
33 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer.
Wei-Lei Yang, Aleksandra Gentry-Maharaj, Archana Simmons, Andy Ryan, Evangelia Ourania Fourkala, Zhen Lu, Keith A Baggerly, Yang Zhao, Karen H Lu, David Bowtell,[...]. Clin Cancer Res 2017
30
62

Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
50

Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer.
Jing Guo, Wei-Lei Yang, Daewoo Pak, Joseph Celestino, Karen H Lu, Jing Ning, Anna E Lokshin, Zhongping Cheng, Zhen Lu, Robert C Bast. Cancers (Basel) 2019
9
50

Autoantibody signature for the serologic detection of ovarian cancer.
Karen S Anderson, Daniel W Cramer, Sahar Sibani, Garrick Wallstrom, Jessica Wong, Jin Park, Ji Qiu, Allison Vitonis, Joshua LaBaer. J Proteome Res 2015
59
37

Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer.
Archana R Simmons, Evangelia Ourania Fourkala, Aleksandra Gentry-Maharaj, Andy Ryan, Margie N Sutton, Keith Baggerly, Hui Zheng, Karen H Lu, Ian Jacobs, Steven Skates,[...]. Cancer Prev Res (Phila) 2019
8
37

Autoantibodies against HSF1 and CCDC155 as Biomarkers of Early-Stage, High-Grade Serous Ovarian Cancer.
Amy L Wilson, Laura R Moffitt, Nadine Duffield, Adam Rainczuk, Tom W Jobling, Magdalena Plebanski, Andrew N Stephens. Cancer Epidemiol Biomarkers Prev 2018
12
37

Evaluation of paraneoplastic antigens reveals TRIM21 autoantibodies as biomarker for early detection of ovarian cancer in combination with autoantibodies to NY-ESO-1 and TP53.
Laura C Hurley, Nancy K Levin, Madhumita Chatterjee, Jasmine Coles, Shlomo Muszkat, Zachary Howarth, Gregory Dyson, Michael A Tainsky. Cancer Biomark 2020
6
50

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.
Steven J Skates, Mark H Greene, Saundra S Buys, Phuong L Mai, Powel Brown, Marion Piedmonte, Gustavo Rodriguez, John O Schorge, Mark Sherman, Mary B Daly,[...]. Clin Cancer Res 2017
53
37

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Ian J Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Jatinderpal K Kalsi, Nazar N Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank,[...]. Lancet 2016
491
37

Biomarkers and Strategies for Early Detection of Ovarian Cancer.
Robert C Bast, Zhen Lu, Chae Young Han, Karen H Lu, Karen S Anderson, Charles W Drescher, Steven J Skates. Cancer Epidemiol Biomarkers Prev 2020
13
37

Epithelial ovarian cancer: Evolution of management in the era of precision medicine.
Stephanie Lheureux, Marsela Braunstein, Amit M Oza. CA Cancer J Clin 2019
258
25

Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention.
Anne Marie Lennon, Adam H Buchanan, Isaac Kinde, Andrew Warren, Ashley Honushefsky, Ariella T Cohain, David H Ledbetter, Fred Sanfilippo, Kathleen Sheridan, Dillenia Rosica,[...]. Science 2020
102
25

Probability of fallopian tube and ovarian detection with transvaginal ultrasonography in normal women.
Jason R Lefringhouse, Erin Neward, Frederick R Ueland, Lauren A Baldwin, Rachel W Miller, Christopher P DeSimone, Richard J Kryscio, John R van Nagell, Edward J Pavlik. Womens Health (Lond) 2016
6
33

The impact of tissue block sampling on the detection of p53 signatures in fallopian tubes from women with BRCA 1 or 2 mutations (BRCA+) and controls.
Karishma K Mehra, Martin C Chang, Ann K Folkins, Caroline J Raho, Joema F Lima, Liping Yuan, Mitra Mehrad, Shelley S Tworoger, Christopher P Crum, Aasia Saleemuddin. Mod Pathol 2011
26
25

Cancer Statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2017
25

Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel.
Matthew R Russell, Ciaren Graham, Alfonsina D'Amato, Aleksandra Gentry-Maharaj, Andy Ryan, Jatinderpal K Kalsi, Anthony D Whetton, Usha Menon, Ian Jacobs, Robert L J Graham. Br J Cancer 2019
10
25

Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference.
Robert C Bast, Ursula A Matulonis, Anil K Sood, Ahmed A Ahmed, Adaobi E Amobi, Frances R Balkwill, Monicka Wielgos-Bonvallet, David D L Bowtell, James D Brenton, Joan S Brugge,[...]. Cancer 2019
19
25

The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer.
Martin Widschwendter, Michal Zikan, Benjamin Wahl, Harri Lempiäinen, Tobias Paprotka, Iona Evans, Allison Jones, Shohreh Ghazali, Daniel Reisel, Johannes Eichner,[...]. Genome Med 2017
65
25

Detection and localization of surgically resectable cancers with a multi-analyte blood test.
Joshua D Cohen, Lu Li, Yuxuan Wang, Christopher Thoburn, Bahman Afsari, Ludmila Danilova, Christopher Douville, Ammar A Javed, Fay Wong, Austin Mattox,[...]. Science 2018
967
25

Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection.
Renée Turzanski Fortner, Antje Damms-Machado, Rudolf Kaaks. Gynecol Oncol 2017
35
25

Sonographers' self-reported visualization of normal postmenopausal ovaries on transvaginal ultrasound is not reliable: results of expert review of archived images from UKCTOCS.
W Stott, S Campbell, A Franchini, O Blyuss, A Zaikin, A Ryan, C Jones, A Gentry-Maharaj, G Fletcher, J Kalsi,[...]. Ultrasound Obstet Gynecol 2018
6
33

A randomized study of screening for ovarian cancer: a multicenter study in Japan.
H Kobayashi, Y Yamada, T Sado, M Sakata, S Yoshida, R Kawaguchi, S Kanayama, H Shigetomi, S Haruta, Y Tsuji,[...]. Int J Gynecol Cancer 2008
153
25

Serial Patterns of Ovarian Cancer Biomarkers in a Prediagnosis Longitudinal Dataset.
Oleg Blyuss, Alex Gentry-Maharaj, Evangelia-Orania Fourkala, Andy Ryan, Alexey Zaikin, Usha Menon, Ian Jacobs, John F Timms. Biomed Res Int 2015
16
25

A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value.
Karen H Lu, Steven Skates, Mary A Hernandez, Deepak Bedi, Therese Bevers, Leroy Leeds, Richard Moore, Cornelius Granai, Steven Harris, William Newland,[...]. Cancer 2013
74
25

Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial.
Saundra S Buys, Edward Partridge, Mark H Greene, Philip C Prorok, Douglas Reding, Thomas L Riley, Patricia Hartge, Richard M Fagerstrom, Lawrence R Ragard, David Chia,[...]. Am J Obstet Gynecol 2005
214
25

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
Ingegerd Hellström, John Raycraft, Martha Hayden-Ledbetter, Jeffrey A Ledbetter, Michèl Schummer, Martin McIntosh, Charles Drescher, Nicole Urban, Karl Erik Hellström. Cancer Res 2003
470
25

Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening.
Charles W Drescher, Sarah Hawley, Jason D Thorpe, Simone Marticke, Martin McIntosh, Sanjiv S Gambhir, Nicole Urban. Cancer Prev Res (Phila) 2012
13
25

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
Adam N Rosenthal, Lindsay S M Fraser, Susan Philpott, Ranjit Manchanda, Matthew Burnell, Philip Badman, Richard Hadwin, Ivana Rizzuto, Elizabeth Benjamin, Naveena Singh,[...]. J Clin Oncol 2017
81
25

Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.
Lauren C Peres, Kara L Cushing-Haugen, Martin Köbel, Holly R Harris, Andrew Berchuck, Mary Anne Rossing, Joellen M Schildkraut, Jennifer A Doherty. J Natl Cancer Inst 2019
127
25

Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer.
Liancheng Zhu, Huiyu Zhuang, Huimin Wang, Mingzi Tan, Carlton L Schwab, Lu Deng, Jian Gao, Yingying Hao, Xiao Li, Song Gao,[...]. Oncotarget 2016
30
25

Detection of the ovarian cancer biomarker CA-125 using chemiluminescence resonance energy transfer to graphene quantum dots.
Israa Al-Ogaidi, Honglei Gou, Zoraida P Aguilar, Shouwu Guo, Alice K Melconian, Abdul Kareem A Al-Kazaz, Fanke Meng, Nianqiang Wu. Chem Commun (Camb) 2014
71
25

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
25

Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer.
Yan Ma, Xiao Wang, Cuipeng Qiu, Jiejie Qin, Keyan Wang, Guiying Sun, Di Jiang, Jitian Li, Lin Wang, Jianxiang Shi,[...]. Cancer Sci 2021
7
28

Fingerprinting the circulating repertoire of antibodies from cancer patients.
Paul J Mintz, Jeri Kim, Kim-Anh Do, Xuemei Wang, Ralph G Zinner, Massimo Cristofanilli, Marco A Arap, Waun Ki Hong, Patricia Troncoso, Christopher J Logothetis,[...]. Nat Biotechnol 2003
260
12

Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer.
Sandra R Pereira-Faca, Rork Kuick, Eric Puravs, Qing Zhang, Alexei L Krasnoselsky, Douglas Phanstiel, Ji Qiu, David E Misek, Robert Hinderer, Martin Tammemagi,[...]. Cancer Res 2007
66
12

Identification of Serological Biomarkers for Early Diagnosis of Lung Cancer Using a Protein Array-Based Approach.
Jianbo Pan, Guang Song, Dunyan Chen, Yadong Li, Shuang Liu, Shaohui Hu, Christian Rosa, Daniel Eichinger, Ignacio Pino, Heng Zhu,[...]. Mol Cell Proteomics 2017
38
12

Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol.
Nese Unver, Oliver Delgado, Kirubel Zeleke, Amber Cumpian, Ximing Tang, Mauricio S Caetano, Hong Wang, Hiroyuki Katayama, Hua Yu, Eva Szabo,[...]. Int J Cancer 2018
23
12

An Eps homology (EH) domain protein that binds to the Ral-GTPase target, RalBP1.
A Yamaguchi, T Urano, T Goi, L A Feig. J Biol Chem 1997
102
12

A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
Ying Liu, Ying Liao, Linlin Xiang, Kuo Jiang, Siyao Li, Mingmei Huangfu, Shilong Sun. Int J Clin Oncol 2017
9
12

Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity.
Michela Capello, Jody V Vykoukal, Hiroyuki Katayama, Leonidas E Bantis, Hong Wang, Deepali L Kundnani, Clemente Aguilar-Bonavides, Mitzi Aguilar, Satyendra C Tripathi, Dilsher S Dhillon,[...]. Nat Commun 2019
67
12

Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays.
Michael E Hudson, Irina Pozdnyakova, Kenneth Haines, Gil Mor, Michael Snyder. Proc Natl Acad Sci U S A 2007
205
12

Characterization of a cleavage stimulation factor, 3' pre-RNA, subunit 2, 64 kDa (CSTF2) as a therapeutic target for lung cancer.
Masato Aragaki, Koji Takahashi, Hirohiko Akiyama, Eiju Tsuchiya, Satoshi Kondo, Yusuke Nakamura, Yataro Daigo. Clin Cancer Res 2011
21
12


Discovery and Validation of a Serologic Autoantibody Panel for Early Diagnosis of Esophageal Squamous Cell Carcinoma.
Jianbo Pan, Qing-Zhu Zheng, Yadong Li, Li-Li Yu, Qing-Wei Wu, Jia-Ying Zheng, Xiao-Jie Pan, Bao-Song Xie, Yan-An Wu, Jiang Qian,[...]. Cancer Epidemiol Biomarkers Prev 2019
10
12

Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains.
Vitor M Faça, Aviva P Ventura, Mathew P Fitzgibbon, Sandra R Pereira-Faça, Sharon J Pitteri, Ann E Green, Renee C Ireton, Qing Zhang, Hong Wang, Kathy C O'Briant,[...]. PLoS One 2008
103
12


Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women.
Jon J Ladd, Timothy Chao, Melissa M Johnson, Ji Qiu, Alice Chin, Rebecca Israel, Sharon J Pitteri, Jianning Mao, Mei Wu, Lynn M Amon,[...]. Cancer Res 2013
42
12

A plasma protein derived TGFβ signature is a prognostic indicator in triple negative breast cancer.
Hiroyuki Katayama, Peiling Tsou, Makoto Kobayashi, Michela Capello, Hong Wang, Francisco Esteva, Mary L Disis, Samir Hanash. NPJ Precis Oncol 2019
9
12


Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer.
Hao Sun, Jian-Xiang Shi, Hong-Fei Zhang, Meng-Tao Xing, Pei Li, Li-Ping Dai, Cheng-Lin Luo, Xiao Wang, Peng Wang, Hua Ye,[...]. Tumour Biol 2017
11
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.